Related Experiment Video
Updated: May 7, 2026
07:44
Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
136
Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models.
Elisabetta Zanoletti1, Gino Marioni, Paola Stritoni
1Department of Neurosciences, Otosurgery Unit, Padova General Hospital, Padova, Italy.
The Laryngoscope
|October 11, 2013
Summary
Dura mater involvement and lymph node status are key prognostic factors for temporal bone squamous cell carcinoma (SCC) recurrence. These findings highlight the need for further research into tumor diffusion pathways.
Area of Science:
- Oncology
- Otorhinolaryngology
- Surgical Pathology
Background:
- Temporal bone squamous cell carcinoma (SCC) is a rare cancer with a poor prognosis in advanced stages.
- Current treatments have limitations in improving outcomes for advanced SCCs.
Purpose of the Study:
- To identify clinicopathological variables influencing outcomes in temporal bone SCC.
- To analyze prognostic factors for disease-free survival (DFS) and disease-specific survival (DSS).
Main Methods:
- Retrospective analysis of 41 patients with temporal bone SCC treated with curative intent.
- Univariate and multivariate statistical analyses were performed.
Main Results:
- Univariate analysis showed correlations between tumor stage, SCC grading, dura mater involvement, and lymph node status with DFS and DSS.
- Multivariate analysis identified dura mater involvement and N status as independent prognostic factors for DFS.
Conclusions:
- Tumor recurrence can occur even with clear surgical margins.
- Further investigation into microscopic tumor spread, especially within bone, is crucial.
- Multi-institutional studies are needed for robust meta-analyses.
Related Concept Videos
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
01:20Comparing the Survival Analysis of Two or More Groups
734
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
734